NovelStem International Corp. (NSTM)
0.0095
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
NovelStem International Free Cash Flow : -0.2295M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2295M |
| March 31, 2026 | -0.2627M |
| December 31, 2025 | -0.1676M |
| September 30, 2025 | -0.1807M |
| June 30, 2025 | -0.2123M |
| March 31, 2025 | -0.2428M |
| December 31, 2024 | -0.272M |
| September 30, 2024 | -0.3116M |
| June 30, 2024 | -0.3215M |
| March 31, 2024 | -0.3934M |
| December 31, 2023 | -0.3483M |
| September 30, 2023 | -0.3949M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| December 31, 2013 | |
| September 30, 2013 | -5.448M |
| June 30, 2013 | -4.844M |
| March 31, 2013 | -4.828M |
| December 31, 2012 | -4.000M |
| September 30, 2012 | -2.607M |
| June 30, 2012 | -6.454M |
| March 31, 2012 | -6.544M |
| December 31, 2011 | -7.977M |
| Date | Value |
|---|---|
| September 30, 2011 | 1.117M |
| June 30, 2011 | 6.025M |
| March 31, 2011 | 3.552M |
| December 31, 2010 | 3.790M |
| September 30, 2010 | -2.762M |
| June 30, 2010 | -2.177M |
| March 31, 2010 | -1.065M |
| December 31, 2009 | -1.112M |
| September 30, 2009 | -2.210M |
| June 30, 2009 | -6.779M |
| March 31, 2009 | -6.918M |
| December 31, 2008 | -8.347M |
| September 30, 2008 | -11.85M |
| June 30, 2008 | -11.78M |
| March 31, 2008 | -10.32M |
| December 31, 2007 | -11.41M |
| September 30, 2007 | -8.154M |
| June 30, 2007 | -5.922M |
| March 31, 2007 | -6.183M |
| December 31, 2006 | -3.898M |
| September 30, 2006 | -3.728M |
| June 30, 2006 | -2.693M |
| March 31, 2006 | -3.577M |
| December 31, 2005 | -4.80M |
| September 30, 2005 | -4.286M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Brainstorm Cell Therapeutics, Inc. | -4.057M |
| Summit Therapeutics, Inc. | -458.40M |
| Kezar Life Sciences, Inc. | -42.03M |
| Protara Therapeutics, Inc. | -66.49M |
| Clene, Inc. | -16.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.0336M |
| Free Cash Flow Per Share (Quarterly) | -0.0007 |
| Free Cash Flow to Equity (Quarterly) | -0.1864M |
| Free Cash Flow to Firm (Quarterly) | 0.0173M |
| Free Cash Flow Yield | -50.73% |